Meunier Carlin & Curfman client Oncolytics Biotech Inc. of Calgary, Alberta, Canada, the assignee of US Patent No. 7,803,385 directed to a modified reovirus for the treatment of cancer, finally received a Certificate of Correction from the US Patent and Trademark Office (USPTO) showing 122 days of patent term adjustment, a patent term adjustment originally and repeatedly denied by the USPTO.
News & Resources
Jessica Keesee and Anthony J. Zucchero, Ph.D. have joined McKeon Meunier Carlin & Curfman, LLC to provide support to several additional key practice areas.
P. Brian Giles, Ph.D., J.D., has joined McKeon Meunier Carlin & Curfman, LLC as an associate attorney focused on patent prosecution, due diligence and patent strategy in the areas of biotechnology, pharmaceuticals and medical devices. Giles graduated magna cum laude from Georgia State University College of Law in 2011.
In his recent article for World Trademark Review, Steve Schaetzel reports on the U.S. Court of Appeals for the Fourth Circuit and its reversal of a Virginia district court's summary judgement ruling that Google's use of trademarks in its AdWords program was not likely to cause confusion as a matter of law.
Steve Schaetzel has published "TTAB Decision Shows That It Pays To Have Prior US Federal Registration" in the World Trademark Review.